Skip to main content
OpenTrials

Clinical trial condition

RNA Virus Infections

Explore clinical trials studying RNA Virus Infections. Study availability and eligibility vary by location and protocol.

15,839 public trials 824 recruiting studies
Refine in advanced search Browse all conditions

RNA Virus Infections trial results

Completed

Safety of and Immune Response to a Prime-Boost Vaccine Regimen in HIV-Uninfected Vaccine-Naive Adults

NCT00820846

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • Alabama CRS Birmingham, Alabama, United States
  • Bridge HIV CRS San Francisco, California, United States
  • The Hope Clinic of the Emory Vaccine Center CRS Decatur, Georgia, United States
  • Brigham and Women's Hospital Vaccine CRS (BWH VCRS) Boston, Massachusetts, United States
View Trial Details
Completed

Evaluating the Immunogenicity of the AIDSVAX B/E Vaccine and the MVA/HIV62B Vaccine in Healthy, HIV-1-Uninfected Adults Who Previously Received MVA/HIV62B in DNA/MVA or MVA/MVA Regimens in HVTN 205

NCT02852005

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • Alabama CRS Birmingham, Alabama, United States
  • Bridge HIV CRS San Francisco, California, United States
  • The Hope Clinic of the Emory Vaccine Center CRS Decatur, Georgia, United States
  • Brigham and Women's Hospital Vaccine CRS (BWH VCRS) Boston, Massachusetts, United States
View Trial Details
Completed

Safety of and Immune Response to a DNA HIV Vaccine (pGA2/JS7) Boosted With a Modified Vaccinia HIV Vaccine (MVA/HIV62) in Healthy Adults

NCT00301184

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • Alabama Vaccine CRS Birmingham, Alabama, United States
  • Project Brave HIV Vaccine CRS Baltimore, Maryland, United States
  • Brigham and Women's Hosp. CRS Boston, Massachusetts, United States
  • Saint Louis Univ. School of Medicine, HVTU St Louis, Missouri, United States
View Trial Details
Completed

A Study to Assess the Safety, Reactogenicity and Immune Response of GlaxoSmithKline (GSK) Biologicals' Investigational Respiratory Syncytial Virus (RSV) Vaccine (GSK3844766A) in Older Adults

NCT03814590

Conditions
Infections, Mononegavirales Infections, Paramyxoviridae Infections, +4 more
Locations
  • GSK Investigational Site Jacksonville, Florida, United States
  • GSK Investigational Site Miami, Florida, United States
  • GSK Investigational Site Stockbridge, Georgia, United States
  • GSK Investigational Site Lenexa, Kansas, United States
View all 21 locations
View Trial Details

Related conditions